Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082407
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2004-05-06
Brief Title:
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Sponsor:
AstraZeneca
Organization:
AstraZeneca